25 XP   0   0   10

Northeast Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Northeast Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Northeast Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Northeast Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Northeast Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Northeast Pharmaceutical Group Co Ltd.

Quick analysis of Northeast Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Northeast Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.61
Expected worth in 1 year
¥3.93
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥0.49
Return On Investment
10.2%

For what price can you sell your share?

Current Price per Share
¥4.82
Expected price per share
¥3.77 - ¥5.04
How sure are you?
50%

1. Valuation of Northeast Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥4.82

Intrinsic Value Per Share

¥7.88 - ¥9.31

Total Value Per Share

¥11.49 - ¥12.92

2. Growth of Northeast Pharmaceutical Group Co Ltd (5 min.)




Is Northeast Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$711.9m$618.3m$64.3m9.4%

How much money is Northeast Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$12.3m$12m$286.8k2.3%
Net Profit Margin4.5%3.9%--

How much money comes from the company's main activities?

3. Financial Health of Northeast Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Northeast Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Northeast Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Northeast Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Northeast Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Northeast Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Northeast Pharmaceutical Group Co Ltd is ¥4.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Northeast Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Northeast Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.61. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Northeast Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.3%0.010.2%0.000.1%0.000.1%0.000.1%
Usd Book Value Change Per Share0.020.3%0.010.2%0.010.2%0.010.2%0.010.2%
Usd Dividend Per Share0.000.0%0.010.1%0.000.1%0.000.1%0.010.1%
Usd Total Gains Per Share0.020.4%0.020.4%0.010.3%0.010.2%0.020.3%
Usd Price Per Share0.74-0.75-0.80-0.89-1.19-
Price to Earnings Ratio13.78-23.74-55.63--66.39-51.41-
Price-to-Total Gains Ratio41.06-45.83-73.18-484.75-392.22-
Price to Book Ratio1.48-1.57-1.84-2.16-4.09-
Price-to-Total Gains Ratio41.06-45.83-73.18-484.75-392.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.66516
Number of shares1503
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (1503 shares)25.5817.24
Gains per Year (1503 shares)102.3268.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1356792234559
2701341944791128
310620129670136197
414126939894182266
5176336500117227335
6211403602141273404
7246470704164318473
8281537806188364542
9317604908211409611
103526711010235455680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%30.04.06.075.0%65.04.019.073.9%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%31.09.00.077.5%63.025.00.071.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%63.00.025.071.6%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%39.01.00.097.5%79.09.00.089.8%

Fundamentals of Northeast Pharmaceutical Group Co Ltd

About Northeast Pharmaceutical Group Co Ltd

Northeast Pharmaceutical Group Co., Ltd. engages in the chemical raw materials, chemical preparations, pharmaceutical, pharmaceutical engineering, biomedicine, and other businesses in China. It offers vitamin products, including vitamin C, vitamin B1, vitamin B6, and levocarnitine series; anti-infection products, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other products.; and reproductive system and sex hormone products comprising carprost, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. The company also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; essence and cannabis-containing series products, including morphine hydrochloride injection, pethidine hydrochloride injection, compound codeine phosphate syrup, morphine hydrochloride tablets, and oxycodone hydrochloride injection; anti-AIDS products comprising kedu/zidovudine tablets, efavirenz tablets, and other products; digestive system products, which include bacillus licheniformis, aluminum magnesium carbonate chewable tablets, and other products; and in vitro biological diagnostic reagent products, such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. In addition, it offers general health products, including chondroitin ammonia sulfate collagen D3 calcium capsules, protein powder, and probiotic powder; and other products, such as amlodipine maleate, narcotine syrup, xiaoke citridin tablets, acetaminophen tablets, qutong tablets, metronidazole tablets, tinidazole tablets, and amphenamine tablets. Further, the company provides obstetrics and gynecology system, urinary system, antiviral, cardiovascular and cerebrovascular, analgesic and analgesic, and biological diagnosis series medicines. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.

Fundamental data was last updated by Penke on 2024-04-13 17:17:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Northeast Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Northeast Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 7.5% means that ¥0.08 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 7.5%. The company is making a profit. +1
  • The TTM is 4.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.5%TTM4.5%+3.0%
TTM4.5%YOY3.9%+0.6%
TTM4.5%5Y2.4%+2.1%
5Y2.4%10Y2.0%+0.4%
1.1.2. Return on Assets

Shows how efficient Northeast Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.9% Return on Assets means that Northeast Pharmaceutical Group Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.6%+0.3%
TTM0.6%YOY0.6%0.0%
TTM0.6%5Y0.4%+0.3%
5Y0.4%10Y0.3%+0.1%
1.1.3. Return on Equity

Shows how efficient Northeast Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.8% Return on Equity means Northeast Pharmaceutical Group Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM1.9%+0.9%
TTM1.9%YOY2.0%-0.1%
TTM1.9%5Y1.1%+0.7%
5Y1.1%10Y1.0%+0.1%

1.2. Operating Efficiency of Northeast Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Northeast Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Northeast Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.4%-4.4%
TTM4.4%YOY3.4%+1.0%
TTM4.4%5Y3.4%+1.0%
5Y3.4%10Y1.8%+1.6%
1.2.2. Operating Ratio

Measures how efficient Northeast Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.46 means that the operating costs are ¥1.46 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 1.463. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.515. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.463TTM1.515-0.051
TTM1.515YOY1.559-0.044
TTM1.5155Y1.542-0.027
5Y1.54210Y1.165+0.377

1.3. Liquidity of Northeast Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Northeast Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.02 means the company has ¥1.02 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 1.022. The company is just able to pay all its short-term debts.
  • The TTM is 1.007. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.022TTM1.007+0.015
TTM1.007YOY0.891+0.116
TTM1.0075Y0.860+0.147
5Y0.86010Y0.499+0.361
1.3.2. Quick Ratio

Measures if Northeast Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.19 means the company can pay off ¥0.19 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 0.190. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.308. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.308-0.119
TTM0.308YOY0.326-0.018
TTM0.3085Y0.336-0.028
5Y0.33610Y0.334+0.002

1.4. Solvency of Northeast Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Northeast Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.66 means that Northeast Pharmaceutical Group Co Ltd assets are financed with 66.2% credit (debt) and the remaining percentage (100% - 66.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 0.662. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.659. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.662TTM0.659+0.003
TTM0.659YOY0.690-0.031
TTM0.6595Y0.681-0.022
5Y0.68110Y0.707-0.026
1.4.2. Debt to Equity Ratio

Measures if Northeast Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 202.8% means that company has ¥2.03 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The MRQ is 2.028. The company is just not able to pay all its debts with equity.
  • The TTM is 1.997. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.028TTM1.997+0.030
TTM1.997YOY2.313-0.316
TTM1.9975Y2.219-0.222
5Y2.21910Y2.573-0.354

2. Market Valuation of Northeast Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Northeast Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Northeast Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 13.78 means the investor is paying ¥13.78 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The EOD is 12.418. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.783. Based on the earnings, the company is underpriced. +1
  • The TTM is 23.741. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD12.418MRQ13.783-1.365
MRQ13.783TTM23.741-9.958
TTM23.741YOY55.633-31.891
TTM23.7415Y-66.391+90.133
5Y-66.39110Y51.413-117.804
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The EOD is 8.553. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.493. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -31.394. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.553MRQ9.493-0.940
MRQ9.493TTM-31.394+40.887
TTM-31.394YOY10.587-41.981
TTM-31.3945Y-10.250-21.144
5Y-10.25010Y0.070-10.320
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Northeast Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Northeast Pharmaceutical Group Co Ltd:

  • The EOD is 1.335. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.482. Based on the equity, the company is underpriced. +1
  • The TTM is 1.574. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.335MRQ1.482-0.147
MRQ1.482TTM1.574-0.092
TTM1.574YOY1.844-0.269
TTM1.5745Y2.164-0.590
5Y2.16410Y4.088-1.924
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Northeast Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1220.081+51%0.071+72%0.055+123%0.062+96%
Book Value Per Share--3.6103.453+5%3.132+15%3.036+19%2.429+49%
Current Ratio--1.0221.007+2%0.891+15%0.860+19%0.499+105%
Debt To Asset Ratio--0.6620.659+1%0.690-4%0.681-3%0.707-6%
Debt To Equity Ratio--2.0281.997+2%2.313-12%2.219-9%2.573-21%
Dividend Per Share--0.0080.042-81%0.025-67%0.028-71%0.047-83%
Eps--0.0970.063+55%0.035+180%0.029+230%0.023+330%
Free Cash Flow Per Share--0.1410.061+130%0.151-7%0.075+89%0.039+262%
Free Cash Flow To Equity Per Share--0.1410.211-33%0.1410%0.105+34%0.087+62%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.850+18%
Intrinsic Value_10Y_max--9.308--------
Intrinsic Value_10Y_min--7.882--------
Intrinsic Value_1Y_max--0.503--------
Intrinsic Value_1Y_min--0.494--------
Intrinsic Value_3Y_max--1.839--------
Intrinsic Value_3Y_min--1.749--------
Intrinsic Value_5Y_max--3.569--------
Intrinsic Value_5Y_min--3.285--------
Market Cap6888262154.240-11%7645702467.7507777779140.788-2%8261281292.358-7%9203601270.885-17%12293570709.924-38%
Net Profit Margin--0.0750.045+68%0.039+92%0.024+214%0.020+282%
Operating Margin---0.044-100%0.034-100%0.034-100%0.018-100%
Operating Ratio--1.4631.515-3%1.559-6%1.542-5%1.165+26%
Pb Ratio1.335-11%1.4821.574-6%1.844-20%2.164-32%4.088-64%
Pe Ratio12.418-11%13.78323.741-42%55.633-75%-66.391+582%51.413-73%
Price Per Share4.820-11%5.3505.428-1%5.775-7%6.436-17%8.600-38%
Price To Free Cash Flow Ratio8.553-11%9.493-31.394+431%10.587-10%-10.250+208%0.070+13380%
Price To Total Gains Ratio36.988-11%41.05645.831-10%73.182-44%484.748-92%392.216-90%
Quick Ratio--0.1900.308-38%0.326-42%0.336-44%0.334-43%
Return On Assets--0.0090.006+48%0.006+46%0.004+153%0.003+212%
Return On Equity--0.0280.019+50%0.020+41%0.011+146%0.010+170%
Total Gains Per Share--0.1300.123+6%0.096+36%0.083+57%0.109+19%
Usd Book Value--711906436.016682733024.546+4%618347423.023+15%599267098.944+19%479351807.535+49%
Usd Book Value Change Per Share--0.0170.011+51%0.010+72%0.008+123%0.009+96%
Usd Book Value Per Share--0.4980.476+5%0.432+15%0.419+19%0.335+49%
Usd Dividend Per Share--0.0010.006-81%0.003-67%0.004-71%0.007-83%
Usd Eps--0.0130.009+55%0.005+180%0.004+230%0.003+330%
Usd Free Cash Flow--27785168.44612120539.343+129%29823237.103-7%14741371.921+88%5372014.607+417%
Usd Free Cash Flow Per Share--0.0190.008+130%0.021-7%0.010+89%0.005+262%
Usd Free Cash Flow To Equity Per Share--0.0190.029-33%0.0190%0.014+34%0.012+62%
Usd Market Cap950580177.285-11%1055106940.5501073333521.429-2%1140056818.345-7%1270096975.382-17%1696512757.970-38%
Usd Price Per Share0.665-11%0.7380.749-1%0.797-7%0.888-17%1.187-38%
Usd Profit--19137640.84812366815.998+55%12079957.841+58%6857662.715+179%4977829.349+284%
Usd Revenue--253815400.943284389538.247-11%303908520.694-16%281531677.432-10%230905158.370+10%
Usd Total Gains Per Share--0.0180.017+6%0.013+36%0.011+57%0.015+19%
 EOD+4 -4MRQTTM+21 -14YOY+21 -145Y+24 -1110Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Northeast Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.418
Price to Book Ratio (EOD)Between0-11.335
Net Profit Margin (MRQ)Greater than00.075
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.190
Current Ratio (MRQ)Greater than11.022
Debt to Asset Ratio (MRQ)Less than10.662
Debt to Equity Ratio (MRQ)Less than12.028
Return on Equity (MRQ)Greater than0.150.028
Return on Assets (MRQ)Greater than0.050.009
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Northeast Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.282
Ma 20Greater thanMa 504.727
Ma 50Greater thanMa 1004.674
Ma 100Greater thanMa 2004.941
OpenGreater thanClose4.730
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  190,412702,394892,806-398,644494,163307,858802,021-910,240-108,219



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets15,273,654
Total Liabilities10,114,911
Total Stockholder Equity4,988,270
 As reported
Total Liabilities 10,114,911
Total Stockholder Equity+ 4,988,270
Total Assets = 15,273,654

Assets

Total Assets15,273,654
Total Current Assets9,783,060
Long-term Assets5,490,594
Total Current Assets
Cash And Cash Equivalents 5,651,183
Net Receivables 1,813,637
Inventory 1,364,090
Other Current Assets 22,164
Total Current Assets  (as reported)9,783,060
Total Current Assets  (calculated)8,851,074
+/- 931,986
Long-term Assets
Property Plant Equipment 4,476,697
Goodwill 26,119
Intangible Assets 824,496
Long-term Assets Other 34,469
Long-term Assets  (as reported)5,490,594
Long-term Assets  (calculated)5,361,780
+/- 128,813

Liabilities & Shareholders' Equity

Total Current Liabilities9,568,488
Long-term Liabilities546,423
Total Stockholder Equity4,988,270
Total Current Liabilities
Short Long Term Debt 1,290,430
Accounts payable 5,777,647
Other Current Liabilities 11,434
Total Current Liabilities  (as reported)9,568,488
Total Current Liabilities  (calculated)7,079,512
+/- 2,488,976
Long-term Liabilities
Long term Debt 150,000
Capital Lease Obligations Min Short Term Debt31,287
Long-term Liabilities Other 202,800
Long-term Liabilities  (as reported)546,423
Long-term Liabilities  (calculated)384,087
+/- 162,336
Total Stockholder Equity
Retained Earnings 1,013,361
Total Stockholder Equity (as reported)4,988,270
Total Stockholder Equity (calculated)1,013,361
+/- 3,974,909
Other
Capital Stock1,429,103
Common Stock Shares Outstanding 1,429,103
Net Invested Capital 6,428,700
Net Working Capital 214,572
Property Plant and Equipment Gross 4,476,697



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
2,603,618
2,669,196
2,599,070
2,755,971
2,757,839
2,790,424
2,774,976
2,680,989
2,690,475
2,746,701
2,785,038
2,521,742
2,388,983
2,550,366
2,534,404
2,434,343
2,321,678
2,547,439
2,617,764
2,297,861
2,154,991
2,215,221
2,366,792
2,207,513
2,442,058
2,442,601
3,108,820
3,051,278
3,291,114
3,504,345
3,865,628
4,103,989
4,329,485
4,637,028
5,192,067
6,078,928
6,004,347
5,911,972
5,638,690
5,605,363
6,031,369
6,289,574
6,100,619
5,872,372
5,974,891
6,058,202
6,212,852
5,993,276
6,273,649
6,416,332
7,712,502
7,554,596
7,688,277
7,937,999
9,360,956
8,572,869
8,926,028
8,733,940
8,510,061
8,692,634
9,133,974
9,703,733
9,782,718
9,789,981
9,962,174
9,959,207
10,291,947
10,593,041
11,327,436
11,525,983
11,945,468
11,718,744
12,353,381
12,257,313
12,480,596
12,539,829
14,053,297
13,840,981
13,021,245
12,165,695
13,359,287
13,556,626
13,890,769
13,179,521
14,013,479
14,807,749
15,236,407
13,810,328
14,186,126
14,004,559
14,540,582
15,273,654
15,273,65414,540,58214,004,55914,186,12613,810,32815,236,40714,807,74914,013,47913,179,52113,890,76913,556,62613,359,28712,165,69513,021,24513,840,98114,053,29712,539,82912,480,59612,257,31312,353,38111,718,74411,945,46811,525,98311,327,43610,593,04110,291,9479,959,2079,962,1749,789,9819,782,7189,703,7339,133,9748,692,6348,510,0618,733,9408,926,0288,572,8699,360,9567,937,9997,688,2777,554,5967,712,5026,416,3326,273,6495,993,2766,212,8526,058,2025,974,8915,872,3726,100,6196,289,5746,031,3695,605,3635,638,6905,911,9726,004,3476,078,9285,192,0674,637,0284,329,4854,103,9893,865,6283,504,3453,291,1143,051,2783,108,8202,442,6012,442,0582,207,5132,366,7922,215,2212,154,9912,297,8612,617,7642,547,4392,321,6782,434,3432,534,4042,550,3662,388,9832,521,7422,785,0382,746,7012,690,4752,680,9892,774,9762,790,4242,757,8392,755,9712,599,0702,669,1962,603,618
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,390,620
6,397,637
5,593,330
6,096,188
5,869,236
5,933,308
5,879,359
7,257,386
7,050,925
6,330,359
5,553,151
6,785,357
7,048,807
7,446,345
6,799,336
7,726,276
8,650,987
9,040,901
7,930,525
8,403,794
8,336,492
8,983,953
9,783,060
9,783,0608,983,9538,336,4928,403,7947,930,5259,040,9018,650,9877,726,2766,799,3367,446,3457,048,8076,785,3575,553,1516,330,3597,050,9257,257,3865,879,3595,933,3085,869,2366,096,1885,593,3306,397,6376,390,620000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,826,604
1,750,412
1,283,581
1,382,178
1,341,408
1,698,520
1,525,403
2,805,739
2,565,713
1,992,333
1,481,274
1,746,925
2,217,251
2,649,308
2,550,407
3,019,494
4,013,197
4,529,682
3,844,899
3,926,951
3,851,533
4,702,985
5,651,183
5,651,1834,702,9853,851,5333,926,9513,844,8994,529,6824,013,1973,019,4942,550,4072,649,3082,217,2511,746,9251,481,2741,992,3332,565,7132,805,7391,525,4031,698,5201,341,4081,382,1781,283,5811,750,4121,826,604000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500,000
500,000
500,000
0
0
0
0
0
0
0
0
0
000000000500,000500,000500,00000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
1,446,954
1,406,521
1,312,843
1,340,233
1,344,695
1,410,523
1,176,578
1,060,986
980,894
1,006,486
1,008,517
909,828
828,162
912,585
776,472
745,877
754,448
963,571
984,489
744,823
760,803
799,934
962,093
818,445
1,001,460
922,034
1,074,073
949,783
1,091,144
1,034,133
1,089,595
798,457
944,058
853,798
1,317,898
860,294
1,064,423
1,158,756
975,033
760,114
1,171,584
1,257,477
1,132,508
814,115
943,538
935,673
995,320
799,820
854,680
970,494
1,099,692
948,464
1,295,958
1,399,568
1,473,270
1,242,639
1,436,020
1,455,181
1,407,961
1,192,329
1,519,899
1,616,874
1,801,143
1,663,934
1,744,040
1,832,667
1,964,262
2,092,661
2,720,927
2,485,941
2,705,727
2,815,609
2,186,818
1,990,348
1,999,235
2,838,505
3,088,537
2,964,168
2,908,543
2,661,318
3,085,374
2,966,081
3,124,705
2,768,463
3,217,710
3,154,646
3,079,434
2,734,963
2,974,231
3,010,891
2,942,569
1,813,637
1,813,6372,942,5693,010,8912,974,2312,734,9633,079,4343,154,6463,217,7102,768,4633,124,7052,966,0813,085,3742,661,3182,908,5432,964,1683,088,5372,838,5051,999,2351,990,3482,186,8182,815,6092,705,7272,485,9412,720,9272,092,6611,964,2621,832,6671,744,0401,663,9341,801,1431,616,8741,519,8991,192,3291,407,9611,455,1811,436,0201,242,6391,473,2701,399,5681,295,958948,4641,099,692970,494854,680799,820995,320935,673943,538814,1151,132,5081,257,4771,171,584760,114975,0331,158,7561,064,423860,2941,317,898853,798944,058798,4571,089,5951,034,1331,091,144949,7831,074,073922,0341,001,460818,445962,093799,934760,803744,823984,489963,571754,448745,877776,472912,585828,162909,8281,008,5171,006,486980,8941,060,9861,176,5781,410,5231,344,6951,340,2331,312,8431,406,5211,446,954
       Other Current Assets 
81,204
95,653
69,322
134,952
141,514
141,905
145,001
109,294
106,925
115,090
100,806
88,055
101,442
90,590
96,180
104,533
97,947
50,703
80,194
84,260
81,791
59,732
54,220
72,672
104,252
21,117
138,960
135,659
187,469
279,259
348,604
314,323
340,147
324,047
363,886
260,965
262,364
236,294
274,545
348,185
339,904
308,206
336,404
161,893
156,688
139,030
174,698
160,222
154,168
195,218
239,262
150,252
135,418
131,118
242,316
149,910
229,914
159,994
185,891
137,746
140,914
158,017
373,025
140,136
510,142
152,479
333,767
415,327
475,837
425,840
478,837
210,057
87,927
112,254
66,737
226,664
208,704
160,986
177,406
145,663
172,227
137,735
180,094
216,564
208,095
150,648
129,251
24,282
132,089
103,261
90,725
22,164
22,16490,725103,261132,08924,282129,251150,648208,095216,564180,094137,735172,227145,663177,406160,986208,704226,66466,737112,25487,927210,057478,837425,840475,837415,327333,767152,479510,142140,136373,025158,017140,914137,746185,891159,994229,914149,910242,316131,118135,418150,252239,262195,218154,168160,222174,698139,030156,688161,893336,404308,206339,904348,185274,545236,294262,364260,965363,886324,047340,147314,323348,604279,259187,469135,659138,96021,117104,25272,67254,22059,73281,79184,26080,19450,70397,947104,53396,18090,590101,44288,055100,806115,090106,925109,294145,001141,905141,514134,95269,32295,65381,204
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,257,193
6,388,077
6,547,289
6,660,470
6,795,910
6,790,055
6,690,886
6,612,544
6,573,930
6,507,819
6,444,423
6,380,185
6,287,204
6,156,762
6,195,506
5,879,803
5,782,332
5,668,067
5,556,629
5,490,594
5,490,5945,556,6295,668,0675,782,3325,879,8036,195,5066,156,7626,287,2046,380,1856,444,4236,507,8196,573,9306,612,5446,690,8866,790,0556,795,9106,660,4706,547,2896,388,0776,257,193000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
562,858
524,389
514,832
515,862
512,242
498,792
530,966
585,278
573,426
562,975
586,505
588,250
566,989
572,462
568,422
558,631
553,783
742,528
580,761
745,434
579,399
698,559
580,986
666,152
533,328
667,110
803,413
975,431
756,599
981,442
802,703
1,485,477
1,155,625
1,486,141
1,219,231
2,477,751
1,716,898
2,562,459
1,752,049
2,608,143
1,798,536
2,771,441
2,101,957
2,951,026
2,133,233
2,982,109
2,265,990
3,096,010
2,339,578
3,187,023
2,518,816
3,531,064
2,830,193
2,940,527
3,106,631
3,412,136
3,493,622
3,618,777
3,746,834
3,816,464
3,767,502
3,749,575
3,734,177
3,721,146
3,680,657
3,722,278
3,779,043
3,792,100
3,770,899
3,814,007
4,135,045
4,781,843
4,927,536
5,040,595
5,233,545
5,421,165
5,642,099
5,600,514
5,523,652
5,488,535
5,451,399
5,359,158
5,285,771
5,226,369
5,115,838
5,005,792
5,040,742
4,852,494
4,751,403
4,636,023
4,542,667
4,476,697
4,476,6974,542,6674,636,0234,751,4034,852,4945,040,7425,005,7925,115,8385,226,3695,285,7715,359,1585,451,3995,488,5355,523,6525,600,5145,642,0995,421,1655,233,5455,040,5954,927,5364,781,8434,135,0453,814,0073,770,8993,792,1003,779,0433,722,2783,680,6573,721,1463,734,1773,749,5753,767,5023,816,4643,746,8343,618,7773,493,6223,412,1363,106,6312,940,5272,830,1933,531,0642,518,8163,187,0232,339,5783,096,0102,265,9902,982,1092,133,2332,951,0262,101,9572,771,4411,798,5362,608,1431,752,0492,562,4591,716,8982,477,7511,219,2311,486,1411,155,6251,485,477802,703981,442756,599975,431803,413667,110533,328666,152580,986698,559579,399745,434580,761742,528553,783558,631568,422572,462566,989588,250586,505562,975573,426585,278530,966498,792512,242515,862514,832524,389562,858
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,951
6,951
15,442
36,941
36,941
37,416
37,416
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,119
26,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11926,11937,41637,41636,94136,94115,4426,9516,9510000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,600
1,600
1,600
7,212
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000007,2121,6001,6001,600000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
155,093
170,442
168,611
165,626
164,979
162,807
163,020
164,880
164,084
142,933
142,319
144,158
117,862
116,160
114,457
112,631
111,610
30,368
109,611
17,755
99,706
7,860
98,773
7,860
105,848
8,241
216,269
3,765
235,380
4,080
235,372
4,980
354,546
6,973
353,048
7,856
863,366
18,178
855,675
21,236
855,125
23,258
874,872
25,057
872,509
21,361
840,561
13,161
829,291
21,179
824,591
19,015
761,420
756,149
750,904
734,210
729,036
734,173
735,638
746,821
742,448
736,405
731,299
748,065
748,260
741,503
746,686
774,235
767,349
726,166
720,209
698,643
868,515
260,280
899,421
920,097
934,714
945,953
954,253
943,599
950,350
964,669
971,360
952,020
951,680
949,941
949,817
828,597
840,025
835,147
829,027
824,496
824,496829,027835,147840,025828,597949,817949,941951,680952,020971,360964,669950,350943,599954,253945,953934,714920,097899,421260,280868,515698,643720,209726,166767,349774,235746,686741,503748,260748,065731,299736,405742,448746,821735,638734,173729,036734,210750,904756,149761,42019,015824,59121,179829,29113,161840,56121,361872,50925,057874,87223,258855,12521,236855,67518,178863,3667,856353,0486,973354,5464,980235,3724,080235,3803,765216,2698,241105,8487,86098,7737,86099,70617,755109,61130,368111,610112,631114,457116,160117,862144,158142,319142,933164,084164,880163,020162,807164,979165,626168,611170,442155,093
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
320,323
338,676
289,526
200,508
89,910
84,767
71,194
62,914
55,419
64,106
72,752
71,337
85,268
62,955
79,727
62,659
60,421
52,393
39,196
34,469
34,46939,19652,39360,42162,65979,72762,95585,26871,33772,75264,10655,41962,91471,19484,76789,910200,508289,526338,676320,323000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,698,020
1,763,668
1,678,408
1,872,609
1,872,349
1,902,105
1,881,390
1,807,708
1,815,217
1,867,592
1,902,361
1,651,482
1,502,817
1,659,105
1,640,995
1,550,323
1,436,011
1,649,678
1,714,471
1,397,793
1,251,201
1,304,234
1,452,752
1,280,026
1,474,575
1,478,264
2,283,770
2,162,057
2,393,852
2,496,769
2,733,633
2,529,449
2,597,720
2,778,982
3,213,316
4,025,348
3,871,787
3,718,920
3,438,742
3,531,626
3,949,032
4,152,156
4,097,551
4,123,014
4,303,483
4,432,328
4,376,973
4,236,851
4,538,030
4,687,486
6,032,601
5,955,543
6,022,784
6,256,190
6,627,941
5,811,692
6,195,305
6,056,211
5,967,470
6,291,623
6,736,050
7,290,126
7,364,967
7,355,972
7,511,326
7,478,773
7,764,690
8,045,026
8,727,391
8,029,102
8,406,375
8,125,906
8,439,592
8,296,083
8,628,569
8,622,001
10,029,134
9,705,707
8,910,675
8,043,489
9,087,624
9,271,983
9,636,610
8,889,245
9,649,877
10,414,437
10,783,463
9,097,073
9,357,665
9,204,833
9,538,149
10,114,911
10,114,9119,538,1499,204,8339,357,6659,097,07310,783,46310,414,4379,649,8778,889,2459,636,6109,271,9839,087,6248,043,4898,910,6759,705,70710,029,1348,622,0018,628,5698,296,0838,439,5928,125,9068,406,3758,029,1028,727,3918,045,0267,764,6907,478,7737,511,3267,355,9727,364,9677,290,1266,736,0506,291,6235,967,4706,056,2116,195,3055,811,6926,627,9416,256,1906,022,7845,955,5436,032,6014,687,4864,538,0304,236,8514,376,9734,432,3284,303,4834,123,0144,097,5514,152,1563,949,0323,531,6263,438,7423,718,9203,871,7874,025,3483,213,3162,778,9822,597,7202,529,4492,733,6332,496,7692,393,8522,162,0572,283,7701,478,2641,474,5751,280,0261,452,7521,304,2341,251,2011,397,7931,714,4711,649,6781,436,0111,550,3231,640,9951,659,1051,502,8171,651,4821,902,3611,867,5921,815,2171,807,7081,881,3901,902,1051,872,3491,872,6091,678,4081,763,6681,698,020
   > Total Current Liabilities 
1,462,133
1,680,536
1,572,337
1,775,072
1,785,960
1,810,188
1,789,473
1,758,144
1,767,694
1,778,533
1,812,696
1,503,640
1,355,231
1,502,397
1,391,163
1,350,402
1,236,199
1,458,740
1,480,476
1,242,055
1,096,156
1,172,765
1,283,671
1,188,944
1,401,610
1,356,257
2,183,521
2,093,560
2,325,346
2,442,239
2,677,503
2,443,410
2,508,793
2,379,079
2,812,993
2,647,114
2,587,753
2,328,876
2,043,184
1,927,931
2,294,927
2,801,934
2,674,369
3,024,941
3,203,838
3,337,640
3,539,309
3,410,395
3,706,927
3,834,332
4,885,047
4,491,653
4,583,701
4,839,611
5,229,941
4,411,939
4,643,917
4,590,178
4,635,374
4,631,051
4,922,229
5,049,761
5,098,021
4,933,496
5,092,420
5,061,986
5,362,801
6,039,831
7,104,232
6,426,674
6,807,534
6,651,377
6,967,478
7,725,437
7,904,523
7,899,248
9,308,235
8,948,743
8,157,283
7,316,205
8,085,460
8,302,493
8,673,809
8,198,602
8,966,254
9,755,444
10,326,696
8,423,128
8,671,323
8,640,555
8,378,833
9,568,488
9,568,4888,378,8338,640,5558,671,3238,423,12810,326,6969,755,4448,966,2548,198,6028,673,8098,302,4938,085,4607,316,2058,157,2838,948,7439,308,2357,899,2487,904,5237,725,4376,967,4786,651,3776,807,5346,426,6747,104,2326,039,8315,362,8015,061,9865,092,4204,933,4965,098,0215,049,7614,922,2294,631,0514,635,3744,590,1784,643,9174,411,9395,229,9414,839,6114,583,7014,491,6534,885,0473,834,3323,706,9273,410,3953,539,3093,337,6403,203,8383,024,9412,674,3692,801,9342,294,9271,927,9312,043,1842,328,8762,587,7532,647,1142,812,9932,379,0792,508,7932,443,4102,677,5032,442,2392,325,3462,093,5602,183,5211,356,2571,401,6101,188,9441,283,6711,172,7651,096,1561,242,0551,480,4761,458,7401,236,1991,350,4021,391,1631,502,3971,355,2311,503,6401,812,6961,778,5331,767,6941,758,1441,789,4731,810,1881,785,9601,775,0721,572,3371,680,5361,462,133
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
274,181
274,181
41,781
2,858,211
2,887,316
2,990,580
2,875,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,875,0002,990,5802,887,3162,858,21141,781274,181274,181000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
274,181
274,181
41,781
2,858,211
2,887,316
2,990,580
2,875,000
3,631,000
3,331,000
2,881,000
2,400,000
3,420,000
2,757,460
2,970,456
2,050,051
2,156,345
2,631,134
2,791,000
1,882,000
2,130,000
1,840,000
1,610,000
1,290,430
1,290,4301,610,0001,840,0002,130,0001,882,0002,791,0002,631,1342,156,3452,050,0512,970,4562,757,4603,420,0002,400,0002,881,0003,331,0003,631,0002,875,0002,990,5802,887,3162,858,21141,781274,181274,181000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
252,458
273,830
274,122
360,322
358,004
415,638
380,922
372,776
395,187
411,454
407,973
521,181
378,830
459,046
465,258
421,244
384,706
412,198
488,060
435,803
436,043
385,763
356,557
356,341
440,458
564,509
448,195
480,409
492,304
558,930
567,659
592,518
642,566
415,043
405,511
680,127
700,073
680,753
606,431
672,225
752,564
872,943
745,803
693,570
734,811
741,965
853,484
768,027
811,876
880,230
779,654
783,188
860,881
992,594
1,064,030
856,085
976,549
970,776
1,001,314
984,825
1,111,602
1,417,012
1,431,838
1,609,934
1,678,661
1,506,878
1,489,352
1,384,044
1,999,015
1,860,042
2,393,958
1,988,290
2,831,411
2,829,983
2,701,502
2,695,735
3,408,998
3,408,469
3,029,082
2,763,939
2,596,181
3,459,384
3,531,506
3,695,801
4,389,071
4,822,771
4,942,284
4,320,490
4,342,768
4,678,278
4,864,012
5,777,647
5,777,6474,864,0124,678,2784,342,7684,320,4904,942,2844,822,7714,389,0713,695,8013,531,5063,459,3842,596,1812,763,9393,029,0823,408,4693,408,9982,695,7352,701,5022,829,9832,831,4111,988,2902,393,9581,860,0421,999,0151,384,0441,489,3521,506,8781,678,6611,609,9341,431,8381,417,0121,111,602984,8251,001,314970,776976,549856,0851,064,030992,594860,881783,188779,654880,230811,876768,027853,484741,965734,811693,570745,803872,943752,564672,225606,431680,753700,073680,127405,511415,043642,566592,518567,659558,930492,304480,409448,195564,509440,458356,341356,557385,763436,043435,803488,060412,198384,706421,244465,258459,046378,830521,181407,973411,454395,187372,776380,922415,638358,004360,322274,122273,830252,458
       Other Current Liabilities 
382,248
381,871
235,780
372,270
550,391
355,577
349,878
340,600
312,209
363,323
380,583
253,195
220,641
323,151
307,309
306,031
314,936
541,160
551,768
280,907
219,658
323,135
492,934
295,767
356,166
202,598
329,741
241,276
394,667
457,035
523,489
287,518
309,283
310,285
750,631
351,136
447,829
245,772
219,572
188,525
225,182
261,810
330,285
301,113
353,254
368,563
383,844
354,278
521,476
568,218
1,533,589
601,998
635,137
512,835
519,227
413,863
410,711
389,721
400,513
406,544
490,946
473,567
513,555
510,934
526,131
498,479
540,462
1,072,241
1,046,413
391,746
996,062
1,099,704
41,781
916,107
916,107
1,739,456
2,253,548
1,633,565
2,243,434
1,756,129
2,065,132
1,624,000
2,168,239
1,671,258
1,487,248
1,669,770
2,586,566
18,623
2,088,335
1,306,709
1,725,735
11,434
11,4341,725,7351,306,7092,088,33518,6232,586,5661,669,7701,487,2481,671,2582,168,2391,624,0002,065,1321,756,1292,243,4341,633,5652,253,5481,739,456916,107916,10741,7811,099,704996,062391,7461,046,4131,072,241540,462498,479526,131510,934513,555473,567490,946406,544400,513389,721410,711413,863519,227512,835635,137601,9981,533,589568,218521,476354,278383,844368,563353,254301,113330,285261,810225,182188,525219,572245,772447,829351,136750,631310,285309,283287,518523,489457,035394,667241,276329,741202,598356,166295,767492,934323,135219,658280,907551,768541,160314,936306,031307,309323,151220,641253,195380,583363,323312,209340,600349,878355,577550,391372,270235,780381,871382,248
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,472,114
570,645
724,046
722,752
720,899
756,964
753,393
727,284
1,002,164
969,490
962,801
690,643
683,623
658,992
456,767
673,945
686,342
564,278
1,159,316
546,423
546,4231,159,316564,278686,342673,945456,767658,992683,623690,643962,801969,4901,002,164727,284753,393756,964720,899722,752724,046570,6451,472,114000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
31,464
36,403
6,707
6,559
6,512
6,512
3,911
3,870
5,406
6,273
6,842
6,836
17,708
17,758
28,921
28,812
27,938
27,244
12,038
18,753
17,899
17,304
21,082
20,965
20,457
15,249
13,497
13,506
14,530
16,130
78,838
81,726
78,702
79,122
365,758
371,558
377,568
383,082
439,748
490,158
506,275
509,235
487,515
489,087
485,276
229,252
211,156
215,803
214,854
509,254
1,357,371
212,350
211,538
216,319
1,115,328
1,265,006
1,131,114
1,125,714
1,111,327
1,114,576
1,111,120
1,137,701
1,123,367
1,349,798
1,117,678
1,342,781
1,120,223
1,118,187
1,121,027
1,117,441
1,095,729
1,093,314
209,445
212,846
572,752
570,899
556,964
553,393
527,284
528,248
504,729
500,822
472,673
467,780
445,175
440,339
418,005
416,073
393,386
389,090
0
0389,090393,386416,073418,005440,339445,175467,780472,673500,822504,729528,248527,284553,393556,964570,899572,752212,846209,4451,093,3141,095,7291,117,4411,121,0271,118,1871,120,2231,342,7811,117,6781,349,7981,123,3671,137,7011,111,1201,114,5761,111,3271,125,7141,131,1141,265,0061,115,328216,319211,538212,3501,357,371509,254214,854215,803211,156229,252485,276489,087487,515509,235506,275490,158439,748383,082377,568371,558365,75879,12278,70281,72678,83816,13014,53013,50613,49715,24920,45720,96521,08217,30417,89918,75312,03827,24427,93828,81228,92117,75817,7086,8366,8426,2735,4063,8703,9116,5126,5126,5596,70736,40331,4640
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
212,626
234,501
156,984
172,373
170,963
217,849
226,458
248,845
267,435
282,212
262,942
277,964
298,582
312,729
302,505
308,993
314,806
322,928
122,363
146,082
133,570
140,975
0
0140,975133,570146,082122,363322,928314,806308,993302,505312,729298,582277,964262,942282,212267,435248,845226,458217,849170,963172,373156,984234,501212,626000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
905,394
905,359
920,493
883,236
885,365
888,210
893,477
873,250
875,247
879,273
882,869
870,260
886,166
891,261
893,409
884,020
885,667
897,761
903,293
900,068
903,790
910,986
914,039
927,487
967,483
961,524
823,244
887,382
895,467
1,005,784
1,130,201
1,571,542
1,728,928
1,855,139
1,974,332
2,019,224
2,092,280
2,150,324
2,155,327
2,031,631
2,039,978
2,035,615
1,901,460
1,663,652
1,586,669
1,542,607
1,753,209
1,671,316
1,647,632
1,637,218
1,588,681
1,503,419
1,568,047
1,583,335
2,634,521
2,664,308
2,633,383
2,578,559
2,449,280
2,289,194
2,285,309
2,292,773
2,295,949
2,314,478
2,325,209
2,353,819
2,392,709
2,433,633
2,485,478
3,376,989
3,418,442
3,470,760
3,790,188
3,842,429
3,728,142
3,810,801
3,914,120
4,006,475
3,966,905
3,980,604
4,129,694
4,140,510
4,106,181
4,143,734
4,212,297
4,240,055
4,297,429
4,559,308
4,671,282
4,636,436
4,834,764
4,988,270
4,988,2704,834,7644,636,4364,671,2824,559,3084,297,4294,240,0554,212,2974,143,7344,106,1814,140,5104,129,6943,980,6043,966,9054,006,4753,914,1203,810,8013,728,1423,842,4293,790,1883,470,7603,418,4423,376,9892,485,4782,433,6332,392,7092,353,8192,325,2092,314,4782,295,9492,292,7732,285,3092,289,1942,449,2802,578,5592,633,3832,664,3082,634,5211,583,3351,568,0471,503,4191,588,6811,637,2181,647,6321,671,3161,753,2091,542,6071,586,6691,663,6521,901,4602,035,6152,039,9782,031,6312,155,3272,150,3242,092,2802,019,2241,974,3321,855,1391,728,9281,571,5421,130,2011,005,784895,467887,382823,244961,524967,483927,487914,039910,986903,790900,068903,293897,761885,667884,020893,409891,261886,166870,260882,869879,273875,247873,250893,477888,210885,365883,236920,493905,359905,394
   Common Stock
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
303,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
333,810
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
474,655
569,586
569,586
569,586
607,199
607,199
904,727
904,727
907,048
1,351,502
1,351,502
1,350,702
1,350,702
1,347,873
1,347,873
1,347,873
1,347,873
1,347,873
1,424,383
1,434,316
1,434,316
1,434,316
1,434,316
0
01,434,3161,434,3161,434,3161,434,3161,424,3831,347,8731,347,8731,347,8731,347,8731,347,8731,350,7021,350,7021,351,5021,351,502907,048904,727904,727607,199607,199569,586569,586569,586474,655474,655474,655474,655474,655474,655474,655474,655474,655474,655474,655474,655474,655474,655474,655333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810333,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810303,810
   Retained Earnings 
35,007
11,099
24,955
0
0
0
5,006
0
0
5,750
10,519
0
0
0
0
0
0
0
0
0
0
0
0
1,517
40,894
35,276
56,939
69,146
77,365
187,756
312,414
369,175
526,560
652,773
772,024
770,194
843,252
915,047
920,111
791,782
800,226
795,859
661,820
400,059
323,078
278,982
489,816
406,545
380,466
368,603
320,089
234,344
398,243
412,734
392,986
421,427
390,455
335,301
199,228
37,069
32,890
40,215
43,147
60,859
71,735
100,554
140,021
179,855
232,079
296,242
336,567
375,054
311,339
300,136
356,523
546,313
526,642
604,525
547,125
558,569
597,251
608,171
573,284
646,814
715,146
740,535
756,082
978,087
1,048,137
969,542
1,054,435
1,013,361
1,013,3611,054,435969,5421,048,137978,087756,082740,535715,146646,814573,284608,171597,251558,569547,125604,525526,642546,313356,523300,136311,339375,054336,567296,242232,079179,855140,021100,55471,73560,85943,14740,21532,89037,069199,228335,301390,455421,427392,986412,734398,243234,344320,089368,603380,466406,545489,816278,982323,078400,059661,820795,859800,226791,782920,111915,047843,252770,194772,024652,773526,560369,175312,414187,75677,36569,14656,93935,27640,8941,51700000000000010,5195,750005,00600024,95511,09935,007
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
1,173
1,063
6,009
1,319
3,971
746
1,874
487
1,659
992
1,556
1,453
2,010
2,648
2,878
5,248
7,766
7,171
7,246
9,147
8,936
0
08,9369,1477,2467,1717,7665,2482,8782,6482,0101,4531,5569921,6594871,8747463,9711,3196,0091,0631,17345000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,243,175
Cost of Revenue-4,890,196
Gross Profit3,352,9793,352,979
 
Operating Income (+$)
Gross Profit3,352,979
Operating Expense-7,596,995
Operating Income646,180-4,244,016
 
Operating Expense (+$)
Research Development97,042
Selling General Administrative2,080,771
Selling And Marketing Expenses0
Operating Expense7,596,9952,177,813
 
Net Interest Income (+$)
Interest Income155,081
Interest Expense-78,360
Other Finance Cost-54,856
Net Interest Income21,865
 
Pretax Income (+$)
Operating Income646,180
Net Interest Income21,865
Other Non-Operating Income Expenses0
Income Before Tax (EBT)488,172646,180
EBIT - interestExpense = -78,360
358,458
436,818
Interest Expense78,360
Earnings Before Interest and Taxes (EBIT)0566,532
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax488,172
Tax Provision-112,194
Net Income From Continuing Ops375,978375,978
Net Income358,458
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-21,865
 

Technical Analysis of Northeast Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Northeast Pharmaceutical Group Co Ltd. The general trend of Northeast Pharmaceutical Group Co Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Northeast Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Northeast Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4.87 < 4.93 < 5.04.

The bearish price targets are: 4.41 > 3.77.

Tweet this
Northeast Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Northeast Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Northeast Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Northeast Pharmaceutical Group Co Ltd. The current macd is -0.00327302.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Northeast Pharmaceutical Group Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Northeast Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Northeast Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Northeast Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNortheast Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Northeast Pharmaceutical Group Co Ltd. The current adx is 11.34.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Northeast Pharmaceutical Group Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Northeast Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Northeast Pharmaceutical Group Co Ltd. The current sar is 4.88341191.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Northeast Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Northeast Pharmaceutical Group Co Ltd. The current rsi is 55.28. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Northeast Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartNortheast Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Northeast Pharmaceutical Group Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Northeast Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Northeast Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartNortheast Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Northeast Pharmaceutical Group Co Ltd. The current cci is 53.54.

Northeast Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartNortheast Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Northeast Pharmaceutical Group Co Ltd. The current cmo is 17.29.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Northeast Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNortheast Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Northeast Pharmaceutical Group Co Ltd. The current willr is -34.92063492.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Northeast Pharmaceutical Group Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Northeast Pharmaceutical Group Co Ltd Daily Williams %R ChartNortheast Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Northeast Pharmaceutical Group Co Ltd.

Northeast Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Northeast Pharmaceutical Group Co Ltd. The current atr is 0.14122468.

Northeast Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartNortheast Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Northeast Pharmaceutical Group Co Ltd. The current obv is 574,173,715.

Northeast Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartNortheast Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Northeast Pharmaceutical Group Co Ltd. The current mfi is 56.03.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Northeast Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartNortheast Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Northeast Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Northeast Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Northeast Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.282
Ma 20Greater thanMa 504.727
Ma 50Greater thanMa 1004.674
Ma 100Greater thanMa 2004.941
OpenGreater thanClose4.730
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Northeast Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Northeast Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Northeast Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Northeast Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Northeast Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Northeast Pharmaceutical Group Co Ltd.

Receive notifications about Northeast Pharmaceutical Group Co Ltd in your mailbox!